SEC Form 4 · accession 0001553878-15-000029
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin P Starr
Director
Period of report
Nov 11, 2015
Accepted (ET)
Nov 13, 2015 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 11, 2015 | M | 25,000 | $9.30 | A | 25,000 | D | |
| Common Stock | Nov 11, 2015 | M | 12,500 | $11.33 | A | 37,500 | D | |
| Common StockF2 | Nov 11, 2015 | S | 2,274 | $105.3117 | D | 35,226 | D | |
| Common StockF3 | Nov 11, 2015 | S | 4,027 | $106.4611 | D | 31,199 | D | |
| Common StockF4 | Nov 11, 2015 | S | 12,606 | $107.3901 | D | 18,593 | D | |
| Common StockF5 | Nov 11, 2015 | S | 15,499 | $108.2258 | D | 3,094 | D | |
| Common StockF6 | Nov 11, 2015 | S | 3,094 | $109.1417 | D | 0 | D | |
| Common Stock | Nov 12, 2015 | M | 12,500 | $11.33 | A | 12,500 | D | |
| Common Stock | Nov 12, 2015 | M | 25,000 | $15.82 | A | 37,500 | D | |
| Common StockF7 | Nov 12, 2015 | S | 35,400 | $100.0135 | D | 2,100 | D | |
| Common StockF8 | Nov 12, 2015 | S | 1,200 | $101.5825 | D | 900 | D | |
| Common StockF9 | Nov 12, 2015 | S | 900 | $103.0089 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F10 | $11.33 | Nov 11, 2015 | M | 12,500 | D | Jun 21, 2013 | Jun 21, 2022 | Common Stock | 12,500 | 12,500 | D |
| Stock Option (right to buy)F10 | $11.33 | Nov 12, 2015 | M | 12,500 | D | Jun 21, 2013 | Jun 21, 2022 | Common Stock | 12,500 | 0 | D |
| Stock Option (right to buy)F10 | $15.82 | Nov 12, 2015 | M | 25,000 | D | Jun 2, 2011 | Jun 2, 2020 | Common Stock | 25,000 | 0 | D |
| Stock Option (right to buy)F10 | $9.30 | Nov 11, 2015 | M | 25,000 | D | Jun 9, 2012 | Jun 9, 2021 | Common Stock | 25,000 | 0 | D |
Explanation of responses
- F1The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2015.
- F10The option vested, in full, on the first anniversary of the Grant Date.
- F2Sale prices ranged from $104.85 to $105.70.
- F3Sale prices ranged from $105.86 to $106.85.
- F4Sale prices ranged from $106.88 to $107.875.
- F5Sale prices ranged from $107.88 to $108.81.
- F6Sale prices ranged from $108.92 to $109.62.
- F7Sale prices ranged from $100.00 to $100.85.
- F8Sale prices ranged from $101.02 to $101.92.
- F9Sale prices ranged from $102.67 to $103.44.